Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2025-12-25 @ 5:03 AM
NCT ID:
NCT00006118
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven progressive unresectable regional or metastatic transitional cell carcinoma of the bladder
* Measurable disease by CT or MRI scan
* Greater than 10 mm
PATIENT CHARACTERISTICS:
Age:
* 18 to 75
Performance status:
* WHO 0-2
Life expectancy:
* At least 3 months
Hematopoietic:
* Absolute neutrophil count at least 1,500/mm\^3
* Platelet count at least 150,000/mm\^3
Hepatic:
* Not specified
Renal:
* Creatinine less than 1.36 mg/dL
Cardiovascular:
* No uncontrolled cardiac disease
* No severe cardiac arrhythmias
Other:
* Not pregnant or nursing
* No other prior malignancy except curatively treated basal cell or squamous cell skin cancer or carcinoma in situ of the cervix
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Prior intravesical immunotherapy for superficial disease allowed
* No prior systemic biologic response modifier therapy for advanced disease
Chemotherapy:
* Prior intravesical chemotherapy for superficial disease allowed
* No prior systemic chemotherapy for advanced disease
Endocrine therapy:
* Not specified
Radiotherapy:
* Prior radiotherapy allowed
Surgery:
* No prior surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00006118
Study Brief:
Protocol Section:
NCT00006118